Coxsackie A group 5 virus strain capable of effectively infecting adult mice

An effective infection and virus strain technology, applied in the direction of positive-sense single-stranded RNA virus, virus, virus/phage, etc., to achieve the effect of strong growth ability

Pending Publication Date: 2020-07-14
WUHAN INST OF BIOLOGICAL PROD CO LTD
View PDF0 Cites 4 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0007] 2. Meng Xiaodan et al. Research on the Epidemiology and Etiology of Hand, Foot and Mouth

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Coxsackie A group 5 virus strain capable of effectively infecting adult mice
  • Coxsackie A group 5 virus strain capable of effectively infecting adult mice
  • Coxsackie A group 5 virus strain capable of effectively infecting adult mice

Examples

Experimental program
Comparison scheme
Effect test

Example Embodiment

[0091] Example 1: Breeding of CV-A5-M14 mouse-adapted strains

[0092] Cultivate the CV-A5-3487R4 / XY / CHN / 2017 virus strain in RD cells (the original strain is not a monoclonal strain, so it needs to be monoclonal after breeding), and measure the virus titer on RD cells according to the Reed-Muench method Degree is 1x10 7 TCID 50 / ml.

[0093] 10 one-day-old SPF Kunming mice were infected with this virus strain by intracranial injection, 20 μL / mice. The mouse brains of dying mice were taken, weighed, 10% (W / V) homogenate was prepared, the supernatant was harvested by centrifugation, and stored at -20°C. The harvested virus was then continued to infect one-day-old suckling mice according to the same infection method, which was repeated three times.

[0094] Infect five-day-old suckling mice in turn, and repeat twice; seven-day-old mice, repeat twice.

[0095] The virus harvested from 7-day-old infected suckling mice was infected with 9-day-old sucking mice in the same way,...

Example Embodiment

[0097] Example 2: Purification of CV-A5-M14 strain

[0098] 1. Plaque purification of CV-A5-M14 virus clone

[0099] (1) 10-fold serial dilution of CV-A5-M14 virus solution, the dilution range is 10 -1 ~10 -6 .

[0100] (2) Take a 6-well plate with 90%-95% confluence of RD cells, add diluted virus suspension at 200 μL / well, and incubate for 2h.

[0101] (3) After the incubation, discard the virus solution. After the 2X low-melting point agarose prepared in advance is melted, it is mixed 1:1 with 2X MEM virus maintenance solution and spread into a 6-well plate, 2ml / well.

[0102] (4) Microscopically inspect the CPE status of each well, pick the CPE-positive clone from the well corresponding to the maximum dilution, and suspend the virus in 300 μL of virus maintenance solution by pipetting and mixing.

[0103] (5) Take 100 μL of harvest solution for ten-fold dilution, with a dilution range of 10 -1 ~10 -3 , repeat the above steps for three consecutive plaque purifications...

Example Embodiment

[0109] Example 3: Determination of CV-A5-M14-611 and CV-A5-M14-111 Whole Genome Sequences

[0110] 1. Viral RNA extraction

[0111] Viral RNA was extracted and purified using a column-type viral RNA extraction and purification kit (Cat. No. B518667) from Sangon Bioengineering (Shanghai) Co.

[0112] 2. Synthesis of cDNA by reverse transcription

[0113] The reaction system for reverse transcription synthesis of cDNA is shown below

[0114]

[0115] (1) Add the reagents to the PCR tube, mix it evenly, put it in the PCR machine, react at 65°C for 5 minutes, and then quickly put it on ice for quenching.

[0116] (2) Add reagents to the above reaction solution, mix evenly, and place in a PCR apparatus at 30°C for 15 minutes; 42°C for 60 minutes; and 70°C for 15 minutes.

[0117] 3. PCR amplification

[0118] (1) Amplification primers: CV-A5 full sequence determination and expansion primers are shown in Table 1, three pairs of primers are used for PCR (1F5R, 6F8R, 9F10R), an...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Titeraaaaaaaaaa
Titeraaaaaaaaaa
Login to view more

Abstract

The invention relates to a coxsackie A group 5 type (CV-A5) virus strain capable of effectively infecting adult young mice. The virus strain is CV-A5-M14-611, and has a complete amino acid sequence shown as SEQ ID NO. 1. The invention also relates to an attenuated strain CV-A5-M14-111 of the CV-A5 virus strain, and the attenuated strain has a complete amino acid sequence shown as SEQ ID NO. 3. Theinvention also relates to application of the virus strain in preparation of an animal model for evaluating vaccines and/or medicines for treating hand, foot and mouth disease (HFMD) and application of the virus strain in preparation of a preparation for evaluating a protection effect of the vaccines for treating the HFMD.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to a Coxsackie group A type 5 virus strain capable of effectively infecting older mice. Background technique [0002] Hand, foot and mouth disease (HFMD) is a statutory Class C infectious disease caused by a variety of enterovirus serotypes. HFMD occurs mostly in children under the age of 5. Current research shows that EV-71, CV-A6, CV-A10, CV-A16, and CV-A5 are the main pathogens causing HFMD. Other enterovirus serotypes in the Coxsackievirus A and B group are also causative agents of HFMD outbreaks and shedding [1] . [0003] CV-A5 belongs to the genus Enterovirus of the family Picornaviridae, with a diameter of about 27-30nm. The virus particles are symmetrically spherical with 20 faces, and the core contains a single-stranded positive-strand RNA genome of about 7400 nucleotide residues. According to literature reports, CV-A5 commonly causes HFMD, herpetic angina (Her...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N7/00C12N7/04C12R1/93
CPCC12N7/00C12N2770/32021Y02A50/30
Inventor 申硕靳卫平吴杰卢佳麦健仪王泽鋆孟胜利
Owner WUHAN INST OF BIOLOGICAL PROD CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products